Galectin Therapeutics (GALT) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts GALT Hot Sheet
Join SI Premium – FREE
Galectin Therapeutics (NASDAQ: GALT) reported Q2 EPS of ($0.20), $0.04 better than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Truist's 2Q26 Off-Cycle Earnings Preview for Cybersecurity Software: 'We favor RBRK and SAIL'
- Elauwit Connection, Inc. (ELWT) Misses Q2 EPS by 44c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
